Beam Therapeutics Financial Overview
Beam Therapeutics's market cap is currently $2.83B. The company's EPS TTM is $-1.1; its P/E ratio is ―; Beam Therapeutics is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $-1.15. See an overview of income statement, balance sheet, and cash flow financials.
